Risk stratification by residual enzyme activity after newborn screening for medium-chain acyl-CoA dehyrogenase deficiency: data from a cohort study

BACKGROUND: Since the introduction of medium-chain acyl coenzyme A dehydrogenase (MCAD) deficiency in population newborn bloodspot screening (NBS) programs, subjects have been identified with variant ACADM (gene encoding MCAD enzyme) genotypes that have never been identified in clinically ascertaine...

Descripción completa

Detalles Bibliográficos
Autores principales: Touw, Catharina M L, Smit, G Peter A, de Vries, Maaike, de Klerk, Johannis B C, Bosch, Annet M, Visser, Gepke, Mulder, Margot F, Rubio-Gozalbo, M Estela, Elvers, Bert, Niezen-Koning, Klary E, Wanders, Ronald J A, Waterham, Hans R, Reijngoud, Dirk-Jan, Derks, Terry G J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3543239/
https://www.ncbi.nlm.nih.gov/pubmed/22630369
http://dx.doi.org/10.1186/1750-1172-7-30

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3543239/
https://www.ncbi.nlm.nih.gov/pubmed/22630369
http://dx.doi.org/10.1186/1750-1172-7-30

Ejemplares similares